Introduction: Vitamin D levels have a substantial correlation with cardiac failure, coronary artery disease and death. The incidence of alcoholic fatty liver disease, a common hepatic disorder, has increased significantly.Aim: The present study was conducted to determine the vitamin D deficiency in Patients with fatty liver disease.Materials and method: The present cross-sectional study was carried out at from January 2026 to June 2026 after taking approval from the ethical committee of the hospital. A total of 110 Individuals of different age groups (above 18 years) diagnosed with NAFLD and admitted to the hospital different wards were enrolled. After gaining informed permission, each patient's entire medical history was collected and recorded using a standardized questionnaire. Abdominal ultrasound results were used to identify NAFLD. Comorbid conditions such ascites, splenomegaly, and hepatomegaly were also seen. An Achitect 25-OH vitamin D test was used to assess serum vitamin D levels. Three values of vitamin D were identified: sufficient (30 ng/mL), deficient (20 ng/mL) and insufficient (20–29 ng/mL). SPSS version 20 was used to analyze the data. Results: A total of 110 individuals with nonalcoholic fatty were included in this study. Out of which 72(65.4%) were female and 38(34.5%) were male. Out of the total participants 50(45.4%) had vitamin deficiency, 19(17.27) had insufficiency and 41(37.2%) had sufficient amount of vitamin D. Individuals aged 41–50 had the higher vitamin D deficiencies 13(52%), whereas those aged 30–40 had the lower vitamin deficiencies 10(26.31%).Age and the degree of vitamin D deficiency however, did not significantly correlate (p > 0.05). The prevalence of vitamin D deficiency was higher in females (34, 47%) than in men (16, 42%) but it was not statistically different ((p > 0.05). Splenomegaly and hepatomegaly were seen in 9% and 23% of individuals, respectively. Patients with these co-morbidities had higher levels of vitamin D insufficiency than those without, and there was a significant (p < 0.05) association between severe vitamin D deficiency and comorbidity.Conclusion: Our study concluded that vitamin D deficiency is strongly associated with fatty liver as well as comorbidities like hepatomegaly, splenomegaly, and ascites.
Nonalcoholic fatty liver disease (NAFLD) includes nonalcoholic steatohepatitis, simple fatty liver, hepatocellular carcinoma and cirrhosis [1]. NAFLD is now the most prevalent chronic liver disease in western nations, with a frequency of up to 30% [2]. According to a research on NAFLD identified by sonography, the disease's prevalence in Korea is thought to be between 16% and 33%[3]. Metabolic syndrome, Obesity and type 2 diabetes have all been linked to NAFLD. Moreover, a number of studies have demonstrated a connection between the pathophysiology of NAFLD and visceral adipose tissue and insulin resistance (IR)[4]. Vitamin D has been often linked to NAFLD in recent years. A biopsy investigation of NAFLD revealed that individuals with NAFLD had lower serum 25-hydroxyvitamin D3 [25(OH)D3] levels than healthy controls, and that the extent of the hepatic
histology of NAFLD participants was correlated with low 25(OH)D3 levels[5]. Furthermore, vitamin D deficits were 26% more prevalent in those suffering from NAFLD than in healthy individuals, according to a recent meta-analysis [6]. Numerous investigations have shown a connection between vitamin D deficiency and IR, obesity, and metabolic syndrome. The link between vitamin D deficiency and NAFLD may be related to metabolic variables because NAFLD is associated with obesity & metabolic syndrome. Nonetheless, a number of studies found a separate association between vitamin D levels with NAFLD. Serum 25(OH) D3 levels and NAFLD were found to be inversely correlated in recent cross-sectional investigations of the Korean population, even after controlling for metabolic disorder or metabolic variables [7, 8]. After adjusting for visceral fats in individuals with diabetes, another investigation on a population-based sample revealed a connection between low vitamin D levels and NAFLD [9]. The development of NAFLD is influenced by a number of connected pathways, and a number of possible risk factors have been identified, including as obesity, insulin resistance, and metabolic syndrome. Numerous studies have demonstrated an unfavorable relationship between adult vitamin D levels and NAFLD [10]. It has long been known that a lack of vitamin D increases the likelihood of developing NAFLD. However, just a few research have looked into and evaluated the relationship between vitamin D insufficiency and NAFLD. The present study was conducted to determine the vitamin D deficiency in Patients with fatty liver.
The present cross-sectional study was carried out at from January 2026 to June 2026 after taking approval from the ethical committee of the hospital. A total of 110 Individuals of different age groups (above 18 years) diagnosed with NAFLD and admitted to the hospital different wards were enrolled. Individuals with chronic liver disease, HBV, HCV and alcohol consumption or alcohol intake >20 g/day were excluded. After gaining informed permission, each patient's entire medical history was collected and recorded using a standardized questionnaire that included demographics, leisure activities, nicotine and alcohol use previous medical history and dietary habits. Abdominal ultrasound results were used to identify NAFLD. The examination results were recorded using a standardized form. The liver, spleen, kidneys and, gallbladder were among the organs assessed. Hepatic steatosis, liver size, and the existence of localized lesions were evaluated. Hepatic steatosis was identified using preset criteria, according to earlier studies [10]. Comorbid conditions such ascites, splenomegaly, and hepatomegaly were also seen. An Achitect 25-OH vitamin D test was used to assess serum vitamin D levels. The assay has a maximum detection limit of 147.8 ng/mL and a low limit of 2.8 ng/mL. Three values of vitamin D were identified: sufficient (30 ng/mL), deficient (20 ng/mL) and insufficient (20–29 ng/mL). SPSS version 20 was used to analyze the data. The database and graphics were created using Microsoft Office Excel. The chi-square test was used to assess categorical data. The significance level was set at a p-value of less than 0.05.
A total of 110 individuals with nonalcoholic fatty were included in this study. Out of which 72(65.4%) were female and 38(34.5%) were male. The most common age group was 30 - 40 years 38(34.5) followed by age group above 50 years 35 (31.8%), 41-50 years 25(22.7%) and aged 18-30 years 12(10.9%).The most common prevalent symptom was abdominal distention 18(16.3%) followed by fatigue and fever 12(10.9%) and weakness 8(7.2%). among the comorbidities the most common complications were hepatomegaly26(23%) followed by splenomegaly 11(10%) and ascites 9(8%) respectively as presented in table 1. Out of the total participants 50(45.4%) had vitamin deficiency, 19(17.27) had insufficiency and 41(37.2%) had sufficient amount of vitamin D as presented in figure 1. The status of vitamin D was stratified by age, gender and co morbidities. Individuals aged 41–50 had the higher vitamin D deficiencies 13(52%), whereas those aged 30–40 had the lower vitamin deficiencies 10(26.31%).Age and the degree of vitamin D deficiency, however, did not significantly correlate (p > 0.05). The prevalence of vitamin D deficiency was higher in females (34, 47%) than in men (16, 42%) but it was not statistically different ((p > 0.05). Splenomegaly and hepatomegaly were seen in 9% and 23% of individuals, respectively. Those with these comorbidities had higher levels of vitamin D insufficiency than those without, and there was a significant (p < 0.05) association between severe vitamin D deficiency and comorbidity shown in table 2.
Table 1. clinical and demographic features of the study population
|
Features |
Frequency/ Percentage |
|
Gender |
|
|
Male |
38(34.5%) |
|
Female |
72(65.4%) |
|
Age groups in years |
|
|
18- 30 years |
12(10.9%) |
|
30 - 40 years |
38(34.5) |
|
41-50 years |
25(22.7%) |
|
above 50 |
35 (31.8%) |
|
Clinical features |
|
|
Polyuria |
3(2.7%) |
|
Weight loss |
3(2.7%) |
|
Weight gain |
2(1.8%) |
|
Nausea |
2(1.8%) |
|
Jaundice |
2(1.8%) |
|
UTI |
3(2.7%) |
|
Vomiting |
2(1.8%) |
|
Headache |
3(2.7%) |
|
Dyspepsia |
5(4.4%) |
|
Diarrhea |
4(3.6%) |
|
Chest pain |
4(3.6%) |
|
Cough |
6(5.4%) |
|
Abdominal distention |
18(16.3%) |
|
Fatigue |
12(10.9%) |
|
Fever |
12(10.9%) |
|
Weakness |
8(7.2%) |
|
Co- morbidities |
|
|
Splenomegaly
|
|
|
Yes |
11(10%) |
|
No |
99(90%) |
|
Hepatomegaly
|
|
|
Yes |
26(23%) |
|
No |
84(77%) |
|
Ascites |
|
|
Yes |
9(8%) |
|
No |
101(92%) |
Table 2.Association of vitamin D deficiency with demographic and clinical features
|
Variables |
|
Status of vitamin D |
P value |
||
|
N |
Deficiency n (%) |
Insufficiency n (%) |
Sufficiency n (%) |
||
|
Gender |
|
|
|
|
|
|
Male |
38 |
16(42%) |
|
22(58%) |
|
|
Female |
72 |
34(47%) |
0(0) |
38(53%) |
0.63 |
|
Age |
|
|
|
|
|
|
18- 30 years |
12 |
4(33.3) |
4(33.3%) |
8(66.6) |
0.72 |
|
30 - 40 years |
38 |
10(26.31%) |
1(2.6) |
27(71.0%) |
|
|
41-50 years |
25 |
13(52%) |
Zero |
12(48%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Splenomegaly
|
YES 11 |
10 (9%) |
0(0) |
0 (0) |
0.001
|
|
NO 99 |
39 (35.3%) |
18 (18.1%) |
42 (42.4) |
||
|
Hepatomegaly
|
YES 26 |
20 (76.9%) |
2 (7.6%) |
4 (15.3) |
0.001
|
|
84 |
30 (35.7) |
17 (20) |
37 (44.0) |
||
|
Ascites
|
9 |
7 (77%) |
2 (23) |
0 (0) |
0.001
|
|
101 |
(40.9) |
18 (17.8) |
42 (41.5) |
||
Although vitamin D's principal role is to regulate bone metabolism, deficiencies in it are linked to several other organ systems. Vitamin D insufficiency increases the risk of peripheral vascular disease, diabetes, hypertension, or hyperlipidemia. Additionally, there is a strong correlation between vitamin D levels and myocardial infarction, cardiac failure, stroke, coronary artery disease (CAD), and incident mortality [12]. Low serum 25(OH)D levels are indicative of vitamin D deficiency, which can be caused by mal absorption, insufficient sun exposure, or poor vitamin D consumption. Vitamin D insufficiency affects 24% to 49% of adults worldwide and has been linked to a number of health problems, including osteoporosis, osteomalacia, and higher fracture risk [13]. Previous research has shown that vitamin D deficiency increases the risk of peripheral vascular disease, hypertension, diabetes, and hyperlipidemia [13], that vitamin D levels are linked to obesity, inflammation, and insulin resistance, and that vitamin D supplementation reduces insulin resistance caused by free fatty acid (FF A) in animal models [14]. With a 32.4% global incidence, non-alcoholic fatty liver disease (NAFLD) is possibly the most prevalent kind of liver disease in adults [15]. The development of NAFLD is influenced by a number of connected pathways, and a number of possible risk factors have been identified, including as obesity, insulin resistance, and metabolic syndrome. Numerous studies have demonstrated an unfavorable relationship between adult vitamin D levels and NAFLD [16]. The present study was conducted to determine the vitamin D deficiency in Patients with fatty liver. Out of the total participants 50(45.4%) had vitamin deficiency, 19(17.27%) had insufficiency and 41(37.2%) had sufficient amount of vitamin D. our study findings are comparable to the study conducted by Kumar et al. they reported vitamin deficiency in 45.0% of the study participants[17]. our study results are not similar to the study conducted by Yodoshi et al[18] in the frequency of vitamin D deficiency was 32%. the differences may be due to the difference in population .They selected mostly children in their study. In our study, vitamin D insufficiency was associated with a higher incidence of
NAFLD. Numerous studies have indicated that vitamin D insufficiency is associated with the incidence and severity of NAFLD, even if the precise association between vitamin D and NAFLD is uncertain [19]. Low vitamin D levels are associated with the development of nonalcoholic fatty liver disease (NAFLD) in persons with normal blood liver enzymes, regardless of metabolic syndrome. With a male-to-female ratio of 36:64, there were more female patients than male patients among the 110 cases under investigation. Lonardo and Suzuki also observed a gender disparity in their study [20]. The prevalence of vitamin D deficiency was higher in females (34, 47%) than in men (16, 42%) but it was not statistically different (p > 0.05).These results are similar to the previous study [17]. Variations in the distribution of fat between men and women may be linked to the gender gap in the prevalence of fatty liver. Individuals aged 41–50 had the higher vitamin D deficiencies 13(52%), whereas those aged 30–40 had the lower vitamin deficiencies 10(26.31%) however it was not significantly noteworthy. These findings are aslo comparable to the previous results [17]. In our study Splenomegaly and hepatomegaly were seen in 9% and 23% of individuals, respectively. Those with these comorbidities had higher levels of vitamin D insufficiency than those without, and there was a significant (p < 0.05) association between severe vitamin D deficiency and comorbidity. These results are comparable to the study carried out by Glass et al[21]. Our study has limitations, notably its single-center design and limited sample size. Eliminating selection bias may not always be possible in cross-sectional research. Survivors may be chosen if people with complications pass away too soon. With older age groups, this is an urgent issue. Further research with a bigger study population is needed to demonstrate a stronger correlation..
Our study concluded that vitamin D deficiency is strongly associated with fatty liver as well as comorbidities like hepatomegaly, splenomegaly, and ascites.